Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Bolus-only versus bolus plus continuous infusion hydromorphone for refractory cancer pain: a prospective, multicenter, randomized noninferiority trial
Par Yan Z, Fu Y, Jin Y et 6 autres.
Contenu en anglais
Résumé
Introduction
Refractory cancer pain (RCP) remains difficult to manage despite guideline-based therapy. Patient-controlled intravenous analgesia (PCIA) is increasingly used, yet the optimal administration mode remains unclear.